Alphagan® P 0.1% : Patient

Compliance

If you've been diagnosed with glaucoma or ocular hypertension (elevated IOP), it's important to continue your ALPHAGAN^® P 0.1% therapy even if you feel fine. Remember, there are no early warning signs or symptoms. You usually can't feel elevated IOP, and only your eye care professional can detect and measure it.

Glaucoma is a lifelong disease, which means treatment is also lifelong. Remembering to take your eyedrops is easier if you make them another part of your daily routine. Committing to taking your medication exactly as prescribed is the best way to manage glaucoma, and may prevent or delay any further vision loss.

You play the most important role in your treatment. The success of your therapy ultimately depends upon you and your ongoing daily commitment to take your glaucoma medication as your doctor prescribed.

Indication: ALPHAGAN^® P 0.1% ophthalmic solution is approved for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Important Safety Information
Contraindication: ALPHAGAN^® P 0.1% is contraindicated in patients receiving monoamine oxidase (MAO) inhibitor therapy.
Precautions: Although ALPHAGAN^® P 0.1% ophthalmic solution had minimal effect on the blood pressure of patients in clinical studies, caution should be exercised in treating patients with severe cardiovascular disease. ALPHAGAN^® P 0.1% should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, or thromboangiitis obliterans.
Adverse reactions: Adverse events occurring in approximately 10% to 20% of the subjects included: allergic conjunctivitis, conjunctival hyperemia, and eye pruritus. Adverse events occurring in approximately 5% to 9% included: burning sensation, conjunctival folliculosis, hypertension, ocular allergic reaction, oral dryness, and visual disturbance.

Please click here for full product information.